ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Study Shows Olleyes VisuALL-K to Be Effective Perimeter for Pediatric Patients That Also Increases Satisfaction

Perimetry, or mapping of the visual field (VF), provides valuable information regarding the integrity of the afferent visual pathways but can be a challenge to complete on children. The test is monotonous, and the machines are built to accommodate adults, which may result in incorrect positioning and discomfort. These limitations may lead to poor performance by children or sometimes preclude testing altogether. 

VisuALL-K leverages virtual reality technology as part of an innovative platform that can be used to map VF defects. The VisuALL-K uses a cloud-based server and the Olleyes web application, which allows office staff to monitor and test anywhere in the clinic. The head-mounted device is adjustable to the smaller head of many pediatric patients, allowing for a better fit and comfort. 

The study conducted at Vanderbilt University Medical Center, in collaboration with the University of Iowa and Wheaton Eye Clinic, shows that the Olleyes VisuALL-K was able to effectively map out the visual field of pediatric patients while also increasing their satisfaction with the testing procedure. The patients found the headset more engaging and were more willing to complete the testing requested.

"We are excited to offer this new visual field testing device to families and their children," said Dr. Sylvia L. Groth, MD, who led the study. "We believe that the Olleyes VisuALL-K will make visual field testing more engaging and interactive for children, leading to more accurate results and better outcomes."

The Olleyes VisuALL VRP (virtual reality platform) is a valuable tool for monitoring the integrity of the afferent visual pathways in children and can aid in the early detection and diagnosis of conditions such as glaucoma.

About Olleyes

Olleyes is a privately held medical software company committed to developing efficient and productive diagnostic technology. Olleyes' life-transforming products are designed for the office and home evaluation of patients with eye diseases like glaucoma, diabetic retinopathy, and age-related macular degeneration. 

The company is led by a management team experienced in the development and commercialization of medical devices. Olleyes' strategy is predicated upon efficiency and accessibility to deliver accurate and repeatable visual tests.

For more information on Olleyes, please visit the company's website at www.olleyes.com 

Contact Information:
Melissa Satta
Marketing Coordinator
sattam@olleyes.com
855-655-3937


Original Source: Study Shows Olleyes VisuALL-K to Be Effective Perimeter for Pediatric Patients That Also Increases Satisfaction
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.